CVS Health Q2 2024 Adj. EPS $1.83 Beats $1.73 Estimate, Sales $91.234B Miss $91.514B Estimate
Portfolio Pulse from Benzinga Newsdesk
CVS Health reported its Q2 2024 earnings with an adjusted EPS of $1.83, beating the estimate of $1.73. However, its sales of $91.234 billion missed the estimate of $91.514 billion.
August 07, 2024 | 10:31 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
CVS Health's Q2 2024 earnings report shows a mixed performance with an adjusted EPS of $1.83 beating estimates, but sales of $91.234 billion missing expectations.
The mixed earnings report for CVS Health, with EPS beating estimates but sales missing, is likely to result in a neutral short-term impact on the stock price. Investors may be encouraged by the EPS beat but concerned about the sales miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100